Explore
Validate
LearnABIN1355875
antibody from antibodies-online
Targeting: MAPK14
CSBP1, CSBP2, CSPB1, Mxi2, p38, PRKM14, PRKM15
Western blotAntibody data
- Antibody Data
- Antigen structure
- References [2]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN1355875 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Mitogen-Activated Protein Kinase 14 (MAPK14) (pTyr182) antibody
- Antibody type
- Polyclonal
- Antigen
- Peptide sequence around phosphorylation site of pThr180or pTyr182 (E-M-T (p) -G-Y (p) -V-A) derived from Human P38 MAPK.
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Epitope
- pTyr182
- Vial size
- 100 μL
- Storage
- 4°C/-20°C
Submitted references Riboflavin and ultraviolet light treatment of platelets triggers p38MAPK signaling: inhibition significantly improves in vitro platelet quality after pathogen reduction treatment.
EphrinBs/EphBs signaling is involved in modulation of spinal nociceptive processing through a mitogen-activated protein kinases-dependent mechanism.
Schubert P, Coupland D, Culibrk B, Goodrich RP, Devine DV
Transfusion 2013 Dec;53(12):3164-73
Transfusion 2013 Dec;53(12):3164-73
EphrinBs/EphBs signaling is involved in modulation of spinal nociceptive processing through a mitogen-activated protein kinases-dependent mechanism.
Ruan JP, Zhang HX, Lu XF, Liu YP, Cao JL
Anesthesiology 2010 May;112(5):1234-49
Anesthesiology 2010 May;112(5):1234-49
No comments: Submit comment
No validations: Submit validation data